An antibiotic-resistant bacteria called Extended Spectrum Beta Lactamase is killing people and swine in Denmark.
Nyhedsavisen newspaper said the bacteria, which has infected more than 350 people in Denmark since 2003, has been implicated in the deaths of several cancer and liver disease patients, the Copenhagen Post reported. Hvidovre Hospital hospital outside Copenhagen said eight patients were diagnosed as having the ESBL bacteria in 2006 and the number jumped 50 percent last year.
Denmark's health officials said the bacteria is being transmitted to humans through pigs but they're not sure how farmers and veterinarians who are not eating infected meat are becoming infected.
"There's no proof that they are being infected on the farms, but where else would they get it?" Luca Guardabassi of the University of Copenhagen said. "It's very worrying that the increased use of antibiotics in agriculture has allowed these resistant strains to spread."
Copyright 2008 by United Press International
Related stories:
Mimic molecules to protect against plague
Bacteria that cause pneumonic plague can evade our first-line defences, making it difficult for the body to fight infection. In fact, a signature of the plague is the lack of an inflammatory response. Now, scientists have discovered a way to protect against death following infection with plague bacteria, by using molecules that can mimic the pathogens. According to research published in the July issue of
Microbiology, these molecules make antibiotics more effective and can even be used to protect against other diseases.
Parasite vaccines within reach
Even though parasites are complex creatures, the mammalian immune response to them is surprisingly simple, leading University of California, Berkeley, researchers to predict that creating vaccines for parasitic diseases such as malaria may be more straightforward than initially thought.
Newly identified enzyme treats deadly bacterial infections in mice
By the time antibiotics made their clinical debut 70 years ago, bacteria had long evolved strategies to shield themselves. For billions of years, bacteria hurled toxic molecules at each other in the struggle to prosper, and those that withstood the chemical onslaught marched on. Now, with an uptick in antibiotic-resistant bacteria reaching alarming proportions, Rockefeller University scientists have identified an enzyme produced in viruses (called bacteriophages) that could stop these one-celled powerhouses dead in their tracks.
Disease-detecting lab in the palm of your hand
Detecting food-borne diseases such as campylobacter and salmonella long before they enter the food chain would help ensure that the dinner on your table is safe to eat.
Bacterial resistance is futile against wound-cleaning laser
A laser-activated antimicrobial offers hope for new treatments of bacterial infections, even those that are resistant to current drugs. Research published today in the open access journal
BMC Microbiology describes the use of a dye, indocyanine green, which produces bacteria-killing chemicals when lit by a specific kind of laser light.
A single VSOP can do a 'proton' magic!
International research group led by Yasushi Okamura, a professor in Japanese National Institute for Physiological Sciences, Okazaki, and Peter Larsson, a professor in Oregon Health & Science University, Oregon, US, found that a single protein of VSOP, Voltage Sensor Only Protein/ Hv1, can carry protons even without making a multimeric complex.
Abortion drug's off-label use may have led to deaths
Preliminary U-M studies indicate that oral use of RU-486's companion drug misoprostol is safe, but vaginal use may undermine body's immune responses. The off-label use of a drug given with RU-486 to terminate a pregnancy may be responsible for a handful of rare, fatal infections seen in women taking the drugs since 2000, a study by University of Michigan scientists suggests.
Test of bacteria toxin delivery system could pave way for new antibiotic drugs
Researchers at the Hebrew University of Jerusalem have achieved a breakthrough in monitoring the toxin-delivery system of highly pathogenic bacteria – an accomplishment that could help pave the way for new drugs that will be capable of neutralizing those germs.